Robert Califf, FDA Comissioner (Graeme Sloan/Sipa USA)(Sipa via AP Images)
June 8, 2023 02:23 PM EDT
R&D

Good clin­i­cal prac­tices: FDA opens up­dat­ed ICH draft guid­ance for com­ments

Zachary Brennan

Senior Editor

The FDA this week re­leased new draft guid­ance that aims to mod­ern­ize clin­i­cal tri­als, with an up­date to the In­ter­na­tion­al Coun­cil …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

As the XBI suf­fers, Q1 shows a few com­fort­ing signs of un­der­ly­ing sta­bil­i­ty

Up­dat­ed: Roche’s $50B US in­vest­ment in­cludes pre­vi­ous build an­nounce­ments

Makary, in one of first com­ments on FDA pol­i­cy, floats new path­way for rare dis­ease drugs

As­traZeneca, Dai­ichi eye first-line breast can­cer mar­ket af­ter En­her­tu's ear­ly Phase 3 win

Chi­na start­up in­jects CRISPR ther­a­py in­to the brain for the first time

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times